These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24461984)

  • 1. Non-standard dose dronedarone in treating atrial fibrillation patients.
    Huang JH; Lin YK; Hsieh MH; Chen SA; Chen YJ
    Int J Cardiol; 2014; 172(1):e214-6. PubMed ID: 24461984
    [No Abstract]   [Full Text] [Related]  

  • 2. Dronedarone: a new treatment for atrial fibrillation.
    Laughlin JC; Kowey PR
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1220-6. PubMed ID: 18702618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and dronedarone: the worker bee and the drone?
    Franz MR; Singh SN
    Heart Rhythm; 2010 Sep; 7(9):1280-1. PubMed ID: 20620232
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. Indirect meta-analysis].
    Preobrazhenskiĭ DV
    Kardiologiia; 2010; 50(1):69-70. PubMed ID: 20144162
    [No Abstract]   [Full Text] [Related]  

  • 5. Concomitant Rivaroxaban and Dronedarone Administration in Patients With Nonvalvular Atrial Fibrillation.
    Escobar C; Arceluz M; Montes de Oca R; Mori R; López-Sendón JL; Merino JL
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):121-122. PubMed ID: 27693025
    [No Abstract]   [Full Text] [Related]  

  • 6. Dronedarone for the treatment of non-permanent atrial fibrillation: National Institute for Health and Clinical Excellence guidance.
    Camm AJ; Savelieva I
    Heart; 2013 Oct; 99(20):1476-80. PubMed ID: 23633548
    [No Abstract]   [Full Text] [Related]  

  • 7. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone (Multaq) for atrial fibrillation.
    Med Lett Drugs Ther; 2009 Oct; 51(1322):78-80. PubMed ID: 19798011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dronedarone started rapidly after amiodarone discontinuation.
    Immordino L; Connolly S; Crijns H; Roy D; Capucci A; Radzik D; Aliot E; Hohnloser S; Kowey P
    Clin Cardiol; 2013 Feb; 36(2):88-95. PubMed ID: 23338943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dronedarone and amiodarone on atrial fibrillatory rate in patients with persistent atrial fibrillation.
    John S; Salmas J; Kornej J; Löbe S; Stridh M; Sörnmo L; Hindricks G; Husser D; Bollmann A
    Int J Cardiol; 2013 Sep; 167(5):2354-6. PubMed ID: 23183245
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of dronedarone for patients with atrial fibrillation.
    Teme T; Goldberger JJ
    Cardiol J; 2013; 20(5):486-90. PubMed ID: 24469871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dronedarone: the new antiarrythmic agent?].
    Brachmann J; Sinha AM
    Herzschrittmacherther Elektrophysiol; 2009 Jun; 20(2):73-5. PubMed ID: 19517208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Between guidelines and regulatory decisions: the odyssey of dronedarone].
    De Ponti F; Mugelli A
    G Ital Cardiol (Rome); 2012 May; 13(5):334-6. PubMed ID: 22539138
    [No Abstract]   [Full Text] [Related]  

  • 15. Amiodarone plus Flecainide combination therapy in patients with Amiodarone refractory paroxysmal atrial fibrillation.
    Kagal DR; Crystal E; Lashevsky I; Tiong I; Lau C; Vitali AC; Newman D
    Int J Cardiol; 2013 Oct; 168(4):4262-3. PubMed ID: 23680597
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dronedarone: a review of characteristics and clinical data.
    Baroletti S; Catella J; Ehle M; Cheng JW
    Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronedarone-current status in management of atrial fibrillation.
    Manakshe G; Rao BH
    Indian Heart J; 2012; 64(2):182-6. PubMed ID: 22572497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2010 Sep; 7(9):1273-9. PubMed ID: 20478403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.